Spatiotemporal modeling reveals high-resolution invasion states in glioblastoma.


Journal

Genome biology
ISSN: 1474-760X
Titre abrégé: Genome Biol
Pays: England
ID NLM: 100960660

Informations de publication

Date de publication:
10 Oct 2024
Historique:
received: 08 12 2023
accepted: 29 09 2024
medline: 11 10 2024
pubmed: 11 10 2024
entrez: 10 10 2024
Statut: epublish

Résumé

Diffuse invasion of glioblastoma cells through normal brain tissue is a key contributor to tumor aggressiveness, resistance to conventional therapies, and dismal prognosis in patients. A deeper understanding of how components of the tumor microenvironment (TME) contribute to overall tumor organization and to programs of invasion may reveal opportunities for improved therapeutic strategies. Towards this goal, we apply a novel computational workflow to a spatiotemporally profiled GBM xenograft cohort, leveraging the ability to distinguish human tumor from mouse TME to overcome previous limitations in the analysis of diffuse invasion. Our analytic approach, based on unsupervised deconvolution, performs reference-free discovery of cell types and cell activities within the complete GBM ecosystem. We present a comprehensive catalogue of 15 tumor cell programs set within the spatiotemporal context of 90 mouse brain and TME cell types, cell activities, and anatomic structures. Distinct tumor programs related to invasion align with routes of perivascular, white matter, and parenchymal invasion. Furthermore, sub-modules of genes serving as program network hubs are highly prognostic in GBM patients. The compendium of programs presented here provides a basis for rational targeting of tumor and/or TME components. We anticipate that our approach will facilitate an ecosystem-level understanding of the immediate and long-term consequences of such perturbations, including the identification of compensatory programs that will inform improved combinatorial therapies.

Sections du résumé

BACKGROUND BACKGROUND
Diffuse invasion of glioblastoma cells through normal brain tissue is a key contributor to tumor aggressiveness, resistance to conventional therapies, and dismal prognosis in patients. A deeper understanding of how components of the tumor microenvironment (TME) contribute to overall tumor organization and to programs of invasion may reveal opportunities for improved therapeutic strategies.
RESULTS RESULTS
Towards this goal, we apply a novel computational workflow to a spatiotemporally profiled GBM xenograft cohort, leveraging the ability to distinguish human tumor from mouse TME to overcome previous limitations in the analysis of diffuse invasion. Our analytic approach, based on unsupervised deconvolution, performs reference-free discovery of cell types and cell activities within the complete GBM ecosystem. We present a comprehensive catalogue of 15 tumor cell programs set within the spatiotemporal context of 90 mouse brain and TME cell types, cell activities, and anatomic structures. Distinct tumor programs related to invasion align with routes of perivascular, white matter, and parenchymal invasion. Furthermore, sub-modules of genes serving as program network hubs are highly prognostic in GBM patients.
CONCLUSION CONCLUSIONS
The compendium of programs presented here provides a basis for rational targeting of tumor and/or TME components. We anticipate that our approach will facilitate an ecosystem-level understanding of the immediate and long-term consequences of such perturbations, including the identification of compensatory programs that will inform improved combinatorial therapies.

Identifiants

pubmed: 39390467
doi: 10.1186/s13059-024-03407-3
pii: 10.1186/s13059-024-03407-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

264

Informations de copyright

© 2024. The Author(s).

Références

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England J Med. 2005;352(10):987–96.
doi: 10.1056/NEJMoa043330
Cuddapah VA, Robel S, Watkins S, Sontheimer H. A neurocentric perspective on glioma invasion. Nat Rev Neurosci. 2014;15(7):455–65.
doi: 10.1038/nrn3765 pubmed: 24946761 pmcid: 5304245
Wang L, Jung J, Babikir H, Shamardani K, Jain S, Feng X, et al. A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets. Nat Cancer. 2022;3(12):1534–52.
doi: 10.1038/s43018-022-00475-x pubmed: 36539501 pmcid: 9767870
Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell. 2019;178(4):835-849.e21.
doi: 10.1016/j.cell.2019.06.024 pubmed: 31327527 pmcid: 6703186
Richards LM, Whitley OKN, MacLeod G, Cavalli FMG, Coutinho FJ, Jaramillo JE, et al. Gradient of developmental and injury response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity. Nat Cancer. 2021;2(2):157–73.
doi: 10.1038/s43018-020-00154-9 pubmed: 35122077
Varn FS, Johnson KC, Martinek J, Huse JT, Nasrallah MP, Wesseling P, et al. Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell. 2022;185(12):2184-2199.e16.
doi: 10.1016/j.cell.2022.04.038 pubmed: 35649412 pmcid: 9189056
De Boeck A, Ahn BY, D’Mello C, Lun X, Menon SV, Alshehri MM, et al. Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression. Nat Commun. 2020;11(1):4997.
doi: 10.1038/s41467-020-18569-4 pubmed: 33020472 pmcid: 7536425
Wang J, Xu SL, Duan JJ, Yi L, Guo YF, Shi Y, et al. Invasion of white matter tracts by glioma stem cells is regulated by a NOTCH1–SOX2 positive-feedback loop. Nat Neurosci. 2019;22(1):91–105.
doi: 10.1038/s41593-018-0285-z pubmed: 30559479
Jung E, Osswald M, Ratliff M, Dogan H, Xie R, Weil S, et al. Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma. Nat Commun. 2021;12(1):1014.
doi: 10.1038/s41467-021-21117-3 pubmed: 33579922 pmcid: 7881116
Sarkar S, Mirzaei R, Zemp FJ, Wei W, Senger DL, Robbins SM, et al. Activation of NOTCH signaling by Tenascin-C promotes growth of human brain tumor-initiating cells. Cancer Res. 2017;77(12):3231–43.
doi: 10.1158/0008-5472.CAN-16-2171 pubmed: 28416488
Comba A, Faisal SM, Dunn PJ, Argento AE, Hollon TC, Al-Holou WN, et al. Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression. Nat Commun. 2022;13(1):3606.
doi: 10.1038/s41467-022-31340-1 pubmed: 35750880 pmcid: 9232499
Bastola S, Pavlyukov MS, Yamashita D, Ghosh S, Cho H, Kagaya N, et al. Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy. Nat Commun. 2020;11(1):4660.
doi: 10.1038/s41467-020-18189-y pubmed: 32938908 pmcid: 7494913
Minata M, Audia A, Shi J, Lu S, Bernstock J, Pavlyukov MS, et al. Phenotypic plasticity of invasive edge glioma stem-like cells in response to ionizing radiation. Cell Rep. 2019;26(7):1893-1905.e7.
doi: 10.1016/j.celrep.2019.01.076 pubmed: 30759398 pmcid: 6594377
Venkatesh HS, Tam LT, Woo PJ, Lennon J, Nagaraja S, Gillespie SM, et al. Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. Nature. 2017;549(7673):533–7.
doi: 10.1038/nature24014 pubmed: 28959975 pmcid: 5891832
Bressan D, Battistoni G, Hannon GJ. The dawn of spatial omics. Science. 2023;381:eabq4964.
doi: 10.1126/science.abq4964 pubmed: 37535749 pmcid: 7614974
Greenwald AC, Darnell NG, Hoefflin R, Simkin D, Gonzalez-Castro LN, Mount C, et al. Integrative spatial analysis reveals a multi-layered organization of glioblastoma. bioRxiv. 2023. https://doi.org/10.1016/j.cell.2024.03.029 .
Ravi VM, Will P, Kueckelhaus J, Sun N, Joseph K, Salié H, et al. Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma. Cancer Cell. 2022;40(6):639-655.e13.
doi: 10.1016/j.ccell.2022.05.009 pubmed: 35700707
Zheng Y, Carrillo-Perez F, Pizurica M, Heiland DH, Gevaert O. Spatial cellular architecture predicts prognosis in glioblastoma. Nat Commun. 2023;14(1):4122.
doi: 10.1038/s41467-023-39933-0 pubmed: 37433817 pmcid: 10336135
Gangoso E, Southgate B, Bradley L, Rus S, Galvez-Cancino F, McGivern N, et al. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. Cell. 2021;184(9):2454-2470.e26.
doi: 10.1016/j.cell.2021.03.023 pubmed: 33857425 pmcid: 8099351
Ren Y, Huang Z, Zhou L, Xiao P, Song J, He P, et al. Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas. Nat Commun. 2023;14(1):1028.
doi: 10.1038/s41467-023-36707-6 pubmed: 36823172 pmcid: 9950149
Andersson A, Bergenstråhle J, Asp M, Bergenstråhle L, Jurek A, Fernández Navarro J, et al. Single-cell and spatial transcriptomics enables probabilistic inference of cell type topography. Commun Biol. 2020;3(1):565.
doi: 10.1038/s42003-020-01247-y pubmed: 33037292 pmcid: 7547664
Cable DM, Murray E, Zou LS, Goeva A, Macosko EZ, Chen F, et al. Robust decomposition of cell type mixtures in spatial transcriptomics. Nat Biotechnol. 2022;40(4):517-526.
Biancalani T, Scalia G, Buffoni L, Avasthi R, Lu Z, Sanger A, et al. Deep learning and alignment of spatially resolved single-cell transcriptomes with Tangram. Nat Methods. 2021;18(11):1352–62.
doi: 10.1038/s41592-021-01264-7 pubmed: 34711971 pmcid: 8566243
Ma Y, Zhou X. Spatially informed cell-type deconvolution for spatial transcriptomics. Nat Biotechnol. 2022;40(9):1349–59.
doi: 10.1038/s41587-022-01273-7 pubmed: 35501392
Elosua-Bayes M, Nieto P, Mereu E, Gut I, Heyn H. SPOTlight: Seeded NMF regression to deconvolute spatial transcriptomics spots with single-cell transcriptomes. Nucleic Acids Res. 2021;49(9):e50.
doi: 10.1093/nar/gkab043 pubmed: 33544846 pmcid: 8136778
Miller BF, Huang F, Atta L, Sahoo A, Fan J. Reference-free cell type deconvolution of multi-cellular pixel-resolution spatially resolved transcriptomics data. Nat Commun. 2022;13(1):2339.
doi: 10.1038/s41467-022-30033-z pubmed: 35487922 pmcid: 9055051
Rodriques SG, Stickels RR, Goeva A, Martin CA, Murray E, Vanderburg CR, et al. Slide-seq: a scalable technology for measuring genome-wide expression at high spatial resolution. Science (1979). 2019;363(6434):1463–7.
Kleshchevnikov V, Shmatko A, Dann E, Aivazidis A, King HW, Li T, et al. Cell 2location maps fine-grained cell types in spatial transcriptomics. Nat Biotechnol. 2022;40(5):661–71.
doi: 10.1038/s41587-021-01139-4 pubmed: 35027729
Coleman K, Hu J, Schroeder A, Lee EB, Li M. SpaDecon: cell-type deconvolution in spatial transcriptomics with semi-supervised learning. Commun Biol. 2023;6(1):378.
doi: 10.1038/s42003-023-04761-x pubmed: 37029267 pmcid: 10082183
Shen Y, Grisdale CJ, Islam SA, Bose P, Lever J, Zhao EY, et al. Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments. Proc Natl Acad Sci U S A. 2019;116(38):19098–108.
doi: 10.1073/pnas.1813495116 pubmed: 31471491 pmcid: 6754609
Kelly JJP, Stechishin O, Chojnacki A, Lun X, Sun B, Senger DL, et al. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Stem Cells. 2009;27(8):1722–33.
doi: 10.1002/stem.98 pubmed: 19544433
Kotliar D, Veres A, Nagy MA, Tabrizi S, Hodis E, Melton DA, et al. Identifying gene expression programs of cell-type identity and cellular activity with single-cell RNA-Seq. Elife. 2019;8:8.
doi: 10.7554/eLife.43803
Zhang M, Pan X, Jung W, Halpern AR, Eichhorn SW, Lei Z, et al. Molecularly defined and spatially resolved cell atlas of the whole mouse brain. Nature. 2023;624:7991.
doi: 10.1038/s41586-023-06808-9
Yao Z, van Velthoven CTJ, Kunst M, Zhang M, McMillen D, Lee C, et al. A high-resolution transcriptomic and spatial atlas of cell types in the whole mouse brain. Nature. 2023;624(7991):317–32.
doi: 10.1038/s41586-023-06812-z pubmed: 38092916 pmcid: 10719114
Jessa S, Blanchet-Cohen A, Krug B, Vladoiu M, Coutelier M, Faury D, et al. Stalled developmental programs at the root of pediatric brain tumors. Nat Genet. 2019;51(12):1702–13.
doi: 10.1038/s41588-019-0531-7 pubmed: 31768071 pmcid: 6885128
Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature. 2007;445(7124):168–76.
doi: 10.1038/nature05453 pubmed: 17151600
Wang Q, Ding SL, Li Y, Royall J, Feng D, Lesnar P, et al. The allen mouse brain common coordinate framework: a 3D reference atlas. Cell. 2020;181(4):936-953.e20.
doi: 10.1016/j.cell.2020.04.007 pubmed: 32386544 pmcid: 8152789
Pombo Antunes AR, Scheyltjens I, Lodi F, Messiaen J, Antoranz A, Duerinck J, et al. Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization. Nat Neurosci. 2021;24(4):595–610.
doi: 10.1038/s41593-020-00789-y pubmed: 33782623
Couturier CP, Ayyadhury S, Le PU, Nadaf J, Monlong J, Riva G, et al. Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy. Nat Commun. 2020;11(1):3406.
doi: 10.1038/s41467-020-17186-5 pubmed: 32641768 pmcid: 7343844
Puchalski RB, Shah N, Miller J, Dalley R, Nomura SR, Yoon JG, et al. An anatomic transcriptional atlas of human glioblastoma. Science (1979). 2018;360(6389):660–3.
Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science (1979). 2014;344(6190):1396–401.
Dusart P, Hallström BM, Renné T, Odeberg J, Uhlén M, Butler LM. A systems-based map of human brain cell-type enriched genes and malignancy-associated endothelial changes. Cell Rep. 2019;29(6):1690-1706.e4.
doi: 10.1016/j.celrep.2019.09.088 pubmed: 31693905
Darmanis S, Sloan SA, Croote D, Mignardi M, Chernikova S, Samghababi P, et al. Single-cell RNA-Seq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma. Cell Rep. 2017;21(5):1399–410.
doi: 10.1016/j.celrep.2017.10.030 pubmed: 29091775 pmcid: 5810554
Verhaak RGW, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98–110.
doi: 10.1016/j.ccr.2009.12.020 pubmed: 20129251 pmcid: 2818769
Doetsch F, García-Verdugo JM, Alvarez-Buylla A. Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci. 1997;17(13):5046–61.
doi: 10.1523/JNEUROSCI.17-13-05046.1997 pubmed: 9185542 pmcid: 6573289
Monteiro AR, Hill R, Pilkington GJ, Madureira PA. The role of hypoxia in glioblastoma invasion. Cells. 2017;6(4):45.
doi: 10.3390/cells6040045 pubmed: 29165393 pmcid: 5755503
Venkataramani V, Yang Y, Schubert MC, Reyhan E, Tetzlaff SK, Wißmann N, et al. Glioblastoma hijacks neuronal mechanisms for brain invasion. Cell. 2022;185(16):2899-2917.e31.
doi: 10.1016/j.cell.2022.06.054 pubmed: 35914528
Das S, Li Z, Noori A, Hyman BT, Serrano-Pozo A. Meta-analysis of mouse transcriptomic studies supports a context-dependent astrocyte reaction in acute CNS injury versus neurodegeneration. J Neuroinflammation. 2020;17(1):227.
doi: 10.1186/s12974-020-01898-y pubmed: 32736565 pmcid: 7393869
Hu X, Deng Q, Ma L, Li Q, Chen Y, Liao Y, et al. Meningeal lymphatic vessels regulate brain tumor drainage and immunity. Cell Res. 2020;30:3.
doi: 10.1038/s41422-020-0287-8
Gragnano F, Sperlongano S, Golia E, Natale F, Bianchi R, Crisci M, et al. The role of von Willebrand factor in vascular inflammation: from pathogenesis to targeted therapy. Mediators Inflamm. 2017;2017:5620314.
doi: 10.1155/2017/5620314 pubmed: 28634421 pmcid: 5467347
Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. Inference and analysis of cell-cell communication using Cell Chat. Nat Commun. 2021;12(1):1088.
doi: 10.1038/s41467-021-21246-9 pubmed: 33597522 pmcid: 7889871
Angenendt L, Wöste M, Mikesch JH, Arteaga MF, Angenendt A, Sandmann S, et al. Calcitonin receptor-like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML. Blood Adv. 2021;5(21):4413–21.
doi: 10.1182/bloodadvances.2021005236 pubmed: 34559198 pmcid: 8579256
Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle. 2009;8(20):3274–84.
doi: 10.4161/cc.8.20.9701 pubmed: 19770585
Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell. 2009;15(6):501–13.
doi: 10.1016/j.ccr.2009.03.018 pubmed: 19477429 pmcid: 2693960
Gu S, Shu L, Zhou L, Wang Y, Xue H, Jin L, et al. Interfering with CALCRL expression inhibits glioma proliferation, promotes apoptosis, and predicts prognosis in low-grade gliomas. Ann Transl Med. 2022;10(23):1277.
doi: 10.21037/atm-22-5154 pubmed: 36618798 pmcid: 9816851
Scherer HJ. Structural development in gliomas. Am J Cancer. 1938;34(3):333–51.
Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573–87.
doi: 10.1016/j.cell.2021.04.048 pubmed: 34062119 pmcid: 8238499
Fernandes AD, Reid JNS, Macklaim JM, McMurrough TA, Edgell DR, Gloor GB. Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis. Microbiome. 2014;2(1):15.
doi: 10.1186/2049-2618-2-15 pubmed: 24910773 pmcid: 4030730
Venkatesh HS, Johung TB, Caretti V, Noll A, Tang Y, Nagaraja S, et al. Neuronal activity promotes glioma growth through neuroligin-3 secretion. Cell. 2015;161(4):803–16.
doi: 10.1016/j.cell.2015.04.012 pubmed: 25913192 pmcid: 4447122
Lustig M, Sakurai T, Grumet M. Nr-CAM promotes neurite outgrowth from peripheral ganglia by a mechanism involving axonin-1 as a neuronal receptor. Dev Biol. 1999;209(2):340–51.
doi: 10.1006/dbio.1999.9250 pubmed: 10328925
Sehgal A, Boynton AL, Young RF, Vermeulen SS, Yonemura KS, Kohler EP, et al. Cell adhesion molecule Nr-CAM is over-expressed in human brain tumors. Int J Cancer. 1998;76(4):451–8.
doi: 10.1002/(SICI)1097-0215(19980518)76:4<451::AID-IJC1>3.0.CO;2-Q pubmed: 9590116
Schuster A, Klein E, Neirinckx V, Knudsen AM, Fabian C, Hau AC, et al. AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion. Nat Commun. 2020;11(1):6366.
doi: 10.1038/s41467-020-20029-y pubmed: 33311477 pmcid: 7732990
Aiken J, Moore JK, Bates EA. TUBA1A mutations identified in lissencephaly patients dominantly disrupt neuronal migration and impair dynein activity. Hum Mol Genet. 2019;28(8):1227–43.
doi: 10.1093/hmg/ddy416 pubmed: 30517687
Belvindrah R, Natarajan K, Shabajee P, Bruel-Jungerman E, Bernard J, Goutierre M, et al. Mutation of the α-tubulin Tuba1a leads to straighter microtubules and perturbs neuronal migration. J Cell Biol. 2017;216(8):2443–61.
doi: 10.1083/jcb.201607074 pubmed: 28687665 pmcid: 5551700
Camby I, Belot N, Lefranc F, Sadeghi N, De Launoit Y, Kaltner H, et al. Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol. 2002;61(7):585–96.
doi: 10.1093/jnen/61.7.585 pubmed: 12125737
Van Woensel M, Mathivet T, Wauthoz N, Rosière R, Garg AD, Agostinis P, et al. Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy. Sci Rep. 2017;7(1):1217.
doi: 10.1038/s41598-017-01279-1 pubmed: 28450700 pmcid: 5430862
Shevchenko V, Arnotskaya N, Pak O, Sharma A, Sharma HS, Khotimchenko Y, et al. Molecular determinants of the interaction between glioblastoma CD133+ cancer stem cells and the extracellular matrix. Int Rev Neurobiol. 2020;151:155–69.
doi: 10.1016/bs.irn.2020.03.005 pubmed: 32448605
Turtoi A, Blomme A, Bianchi E, Maris P, Vannozzi R, Naccarato AG, et al. Accessibilome of human glioblastoma: Collagen-VI-alpha-1 is a new target and a marker of poor outcome. J Proteome Res. 2014;13(12):5660–9.
doi: 10.1021/pr500657w pubmed: 25325876
Sharma N, Atolagbe OT, Ge Z, Allison JP. LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy. J Exp Med. 2021;218(7):e20201811.
doi: 10.1084/jem.20201811 pubmed: 33974041 pmcid: 8117208
Xiong A, Zhang J, Chen Y, Zhang Y, Yang F. Integrated single-cell transcriptomic analyses reveal that GPNMB-high macrophages promote PN-MES transition and impede T cell activation in GBM. EBioMedicine. 2022;83:104239.
doi: 10.1016/j.ebiom.2022.104239 pubmed: 36054938 pmcid: 9437813
Lun X, Wells JC, Grinshtein N, King JC, Hao X, Dang NH, et al. Disulfiram when combined with copper enhances the therapeutic effects of temozolomide for the treatment of glioblastoma. Clin Cancer Res. 2016;22(15):3860–75.
doi: 10.1158/1078-0432.CCR-15-1798 pubmed: 27006494
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21.
doi: 10.1093/bioinformatics/bts635 pubmed: 23104886
Shi H, He Y, Zhou Y, Huang J, Maher K, Wang B, et al. Spatial atlas of the mouse central nervous system at molecular resolution. Nature. 2023;622(7983):552–61.
doi: 10.1038/s41586-023-06569-5 pubmed: 37758947 pmcid: 10709140
Kolberg L, Raudvere U, Kuzmin I, Adler P, Vilo J, Peterson H. G:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update). Nucleic Acids Res. 2023;51(W1):W207–12.
doi: 10.1093/nar/gkad347 pubmed: 37144459 pmcid: 10320099
Aibar S, González-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14(11):1083–6.
doi: 10.1038/nmeth.4463 pubmed: 28991892 pmcid: 5937676
Tickle T, Tirosh I, Georgescu C, Brown M, Haas B. inferCNV of the Trinity CTAT Project. 2019.
Liu Y, Wang T, Duggan B, Sharpnack M, Huang K, Zhang J, et al. SPCS: a spatial and pattern combined smoothing method for spatial transcriptomic expression. Brief Bioinform. 2022;23(3):bbac116.
doi: 10.1093/bib/bbac116 pubmed: 35380614 pmcid: 9116229
Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:43(D1).
doi: 10.1093/nar/gku1003
Weinstein JN, Collisson EA, Mills GB, Shaw KRM, Ozenberger BA, Ellrott K, et al. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45(10):1113–20.
doi: 10.1038/ng.2764 pubmed: 24071849 pmcid: 3919969
Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:47(W1).
doi: 10.1093/nar/gkz430
Jessa S, Blanchet-Cohen A, Krug B, Vladoiu M et al. Single-cell atlas of the developing brain to investigate the cellular origins of pediatric brain tumors. Gene Expression Omnibus. 2019. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE133531 .
Kleshchevnikov V. 10X Visium spatial RNA-seq from adult mouse brain sections paired to single-nucleus RNA-seq. Array Expression. 2022. https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-11114
Kleshchevnikov V. Single-nucleus RNA-seq from adult mouse brain sections paired to 10X Visium spatial RNA-seq. Array Expression. 2022 https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-11114
Pombo Antunes AR, Scheyltjens I, Lodi F, Messiaen J et al. Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization. Gene Expression Omnibus. 2020. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163120
De Boeck A, Ahn BY, D'Mello C, Lun X et al. Single cell profiling of cerebral immune cells in the Interleukin-33 (IL-33) driven tumor microenvironment. Gene Expression Omnibus. 2020. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE153487 .
Laura M. Richards, Owen K. N. Whitley, Graham MacLeod, Florence M. G. Cavalli et al. Gradient of developmental and injury response transcriptional states define functional vulnerabilities underpinning glioblastoma heterogeneity. Single Cell Portal. 2021. https://singlecell.broadinstitute.org/single_cell/study/SCP503/gradient-of-developmental-and-injury-reponse-transcriptional-states-define-functional-vulnerabilities-underpinning-glioblastoma-heterogeneity#study-summary .
Ravi V, Will P, Kueckelhaus J, Sun N, Joseph K, et al. Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma. Dryad. 2022. https://doi.org/10.5061/dryad.h70rxwdmj .
doi: 10.5061/dryad.h70rxwdmj
Shen Y, Grisdale CJ, Islan SA, Bose P, Lever J, et al. Comprehensive genomic profiling of matched glioblastoma tumours, cell-lines, and xenografts reveals genomic stability and adaptation to disparate growth environments. European Genome-Phenome Archive. 2019. https://ega-archive.org/studies/EGAS00001002709 .
Shi H, He Y, Zhou Y, Huang J, Maher K, Wang B, et al. Spatial atlas of molecular cell types and AAV accessibility across the mouse central nervous system. Single Cell Portal. 2023. https://doi.org/10.1038/s41586-023-06569-5 .
Goldman, M.J., Craft, B., Hastie, M. et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol (2020) UCSC Xena https://xenabrowser.net/datapages/?cohort=TCGA%20TARGET%20GTEx&removeHub=https%3A%2F%2Fxena.treehouse.gi.ucsc.edu%3A443
Manoharan VT, Abdelkareem A, Brown S, Gillmor A, Hall C, Seo H, et al. Spatiotemporal modeling reveals high-resolution invasion states in glioblastoma. Dryad. 2024. https://doi.org/10.5061/dryad.wpzgmsbv6 .
doi: 10.5061/dryad.wpzgmsbv6
Manoharan VT, Abdelkareem A, Brown S, Gillmor A, Hall C, Seo H, et al. 10x Visium spatial RNA-Seq of human GBM cell-line derived murine orthotopic xenograft. Sequence Read Archive, 2024. https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA1137934
Manoharan VT, Abdelkareem A, Brown S, Gillmor A, Hall C, Seo H, et al. GBM xenograft – spatial transcriptomics. 2024. https://github.com/MorrissyLab/GBM_Xenograft_SpatialTranscriptomics

Auteurs

Varsha Thoppey Manoharan (VT)

Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada.
Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.

Aly Abdelkareem (A)

Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada.
Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.

Gurveer Gill (G)

Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada.
Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.

Samuel Brown (S)

Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada.
Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.

Aaron Gillmor (A)

Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada.
Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.

Courtney Hall (C)

Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada.
Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.

Heewon Seo (H)

Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada.
Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.

Kiran Narta (K)

Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada.
Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.

Sean Grewal (S)

Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada.
Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.

Ngoc Ha Dang (NH)

Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.

Bo Young Ahn (BY)

Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.

Kata Osz (K)

Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.

Xueqing Lun (X)

Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.

Laura Mah (L)

Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.
Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Franz Zemp (F)

Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada.
Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.

Douglas Mahoney (D)

Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.
Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB, Canada.

Donna L Senger (DL)

Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada. donna.senger@mcgill.ca.
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada. donna.senger@mcgill.ca.

Jennifer A Chan (JA)

Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada. jawchan@ucalgary.ca.
Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada. jawchan@ucalgary.ca.
Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB, Canada. jawchan@ucalgary.ca.

A Sorana Morrissy (AS)

Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada. sorana.morrissy@ucalgary.ca.
Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada. sorana.morrissy@ucalgary.ca.
Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB, Canada. sorana.morrissy@ucalgary.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH